PANX1 and colitis: To block ATP release from cells, we employed carbenoxolone (CBX), a specific inhibitor of PANX1, and noted that CBX treatment drastically decreased extracellular ATP levels in colon tissues of colitis mice (Fig. 2a), suggesting that CBX administration significantly inhibits ATP release by colon cells during the process of DSS-induced colitis.